Arrow International central access kits recalled for supplier quality issues affecting drug sterility
What this means
Arrow International included lidocaine, bupivacaine, and saline solutions from a supplier with quality issues in three central access kits. The supplier's quality problems and limited reports of drug ineffectiveness raise concerns that sterility may be compromised, which could lead to serious infection or other life-threatening complications.
- If you use these kits in a healthcare setting, stop using affected lots immediately
- Check your inventory against the lot numbers: 33F26C0515, 33F26C0517, and 33F26C0518
- Contact your supplier or Arrow International for instructions on returns or replacement
The agency's original wording
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2390-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.